Researchers controlled inflammation from multiple sclerosis in mice by programming immune cells to target glioblastoma. There will soon be a clinical trial to test the glioblastoma technique.
Disease Biology
The treatment of numerous severe illnesses, including cancer, may improve as a result of a recently published study headed by Wayne State University on a novel understanding of chronic inflammation. Their findings were published in the journal Frontiers in Immunology. According to Dr. Maddipati’s research, acute inflammation which is caused […]
T cells gradually lose their effectiveness when exposed to tumors repeatedly because they express coinhibitory receptors, which function as brakes.
Teri Boudreaux is thankful for the time she gets to spend with her family, whether it’s hiking, playing with her grandkids, travelling with her spouse, lounging on the beach, or taking up new interests like pickleball. She has survived breast cancer twice. In spite of everything, though, she still harbours […]
However, it’s also known that TET2 mutations can result in conditions other than cancer. A portion of persons over the age of 70 also had TET2 mutations, which raise the risk of diabetes, heart disease, stroke, and other inflammatory diseases as well as CHIP.
Here the investigators infected mice with SARS-CoV-2 and sequenced the genomes of viruses replicating in the brain versus the lung. In the lung, spike protein had a very close structure to the infecting virus.
New findings out of Emory University are shaking theories of the origin of Alzheimer’s the leading cause of dementia among older adults worldwide.
The first study in the world, conducted recently at the University of Eastern Finland, demonstrates that even in those with a high hereditary risk, type 2 diabetes may be prevented with a balanced diet and frequent exercise. Put another way, regardless of hereditary risk, everyone gains from changing their lifestyle. […]
Recently, Japanese researchers discovered endolysin, an enzyme generated from bacteriophages that may attack Enterococcus faecalis biofilms. Their results provide promise for customized allo-HCT therapies.
The study investigated if cancer status differed according to individuals’ RAS genetic variations.
